Stryker Co. (NYSE:SYK) Stock Position Lifted by AMI Investment Management Inc.

AMI Investment Management Inc. boosted its position in shares of Stryker Co. (NYSE:SYK) by 1.8% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 7,051 shares of the medical technology company’s stock after buying an additional 127 shares during the period. AMI Investment Management Inc.’s holdings in Stryker were worth $2,112,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of SYK. Fairfield Bush & CO. purchased a new stake in shares of Stryker during the first quarter valued at $131,000. Dimensional Fund Advisors LP lifted its holdings in shares of Stryker by 1.4% during the first quarter. Dimensional Fund Advisors LP now owns 673,924 shares of the medical technology company’s stock valued at $180,182,000 after purchasing an additional 9,026 shares during the last quarter. Prudential PLC purchased a new stake in shares of Stryker during the first quarter valued at $1,444,000. Sequoia Financial Advisors LLC lifted its holdings in shares of Stryker by 21.6% during the first quarter. Sequoia Financial Advisors LLC now owns 3,056 shares of the medical technology company’s stock valued at $817,000 after purchasing an additional 543 shares during the last quarter. Finally, Zions Bancorporation N.A. lifted its holdings in shares of Stryker by 9.2% during the first quarter. Zions Bancorporation N.A. now owns 3,140 shares of the medical technology company’s stock valued at $839,000 after purchasing an additional 265 shares during the last quarter. Institutional investors own 77.09% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on SYK. Citigroup increased their price objective on Stryker from $340.00 to $362.00 and gave the stock a “buy” rating in a research note on Wednesday, January 31st. StockNews.com raised Stryker from a “hold” rating to a “buy” rating in a research report on Tuesday, January 23rd. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $360.00 target price on shares of Stryker in a research report on Thursday, February 15th. Truist Financial increased their price objective on Stryker from $330.00 to $345.00 and gave the company a “hold” rating in a report on Wednesday, January 31st. Finally, Roth Mkm increased their price objective on Stryker from $345.00 to $348.00 and gave the company a “buy” rating in a report on Wednesday, January 31st. Three research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat.com, Stryker has a consensus rating of “Moderate Buy” and a consensus price target of $331.52.

Insider Buying and Selling

In other Stryker news, Director Allan C. Golston sold 3,273 shares of Stryker stock in a transaction dated Friday, February 2nd. The stock was sold at an average price of $341.00, for a total transaction of $1,116,093.00. Following the transaction, the director now directly owns 14,242 shares in the company, valued at $4,856,522. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other Stryker news, Director Allan C. Golston sold 3,273 shares of Stryker stock in a transaction dated Friday, February 2nd. The stock was sold at an average price of $341.00, for a total transaction of $1,116,093.00. Following the transaction, the director now directly owns 14,242 shares in the company, valued at $4,856,522. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CAO William E. Berry, Jr. sold 7,690 shares of Stryker stock in a transaction dated Thursday, March 7th. The stock was sold at an average price of $358.48, for a total value of $2,756,711.20. Following the transaction, the chief accounting officer now owns 3,675 shares in the company, valued at $1,317,414. The disclosure for this sale can be found here. Insiders sold a total of 212,109 shares of company stock valued at $72,845,768 over the last three months. Company insiders own 5.90% of the company’s stock.

Stryker Stock Down 0.2 %

NYSE SYK opened at $357.87 on Friday. The stock has a fifty day moving average of $343.42 and a 200-day moving average of $305.60. The stock has a market capitalization of $136.16 billion, a P/E ratio of 43.38, a price-to-earnings-growth ratio of 2.92 and a beta of 0.89. Stryker Co. has a 52 week low of $249.98 and a 52 week high of $361.41. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.97 and a current ratio of 1.58.

Stryker (NYSE:SYK) last released its earnings results on Tuesday, January 30th. The medical technology company reported $3.46 EPS for the quarter, beating the consensus estimate of $3.27 by $0.19. Stryker had a return on equity of 22.99% and a net margin of 15.44%. The company had revenue of $5.82 billion during the quarter, compared to analysts’ expectations of $5.60 billion. During the same period last year, the firm earned $3.00 EPS. The business’s revenue for the quarter was up 11.8% on a year-over-year basis. On average, equities research analysts forecast that Stryker Co. will post 11.86 EPS for the current year.

Stryker Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 30th. Investors of record on Friday, March 29th will be paid a dividend of $0.80 per share. The ex-dividend date is Wednesday, March 27th. This represents a $3.20 dividend on an annualized basis and a dividend yield of 0.89%. Stryker’s dividend payout ratio (DPR) is presently 38.79%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.